Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710

Recent advances with liposomes as pharmaceutical carriers

Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282

Nanoparticle therapeutics: an emerging treatment modality for cancer

Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233

Delivering nanomedicine to solid tumors

Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,265

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170

Collagens—structure, function, and biosynthesis

Gelse, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.002 · Cited by 2,777

Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794

Molecular mechanisms of drug resistance

Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,726

Role of extracellular matrix assembly in interstitial transport in solid tumors.

Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165

Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation

Brown, E. B., McKee, T. D., DiTomaso, E., Pluen, A., Seed, B., Boucher, Y., & Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm879 · Cited by 844

Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer

García-Domínguez, D. J., López-Enríquez, S., Álba, G., Garnacho, C., Jiménez‐Cortegana, C., Flores-Campos, R., de la Cruz‐Merino, L., Hajji, N., Sánchez‐Margalet, V., & Hontecillas‐Prieto, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021195 · Cited by 26

The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives

Poyia, F., Neophytou, C. M., Christodoulou, M., & Papageorgis, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179555 · Cited by 30

Extracellular matrix re-normalization to improve cold tumor penetration by oncolytic viruses

Soko, G. F., Kosgei, B. K., Meena, S. S., Ng, Y. J., Liang, H., Zhang, B., Liu, Q., Xu, T., Hou, X., & Han, R. P. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1535647 · Cited by 25

A PTT-Induced Feed-Back Carbon Nanosystem for Enhanced Breast Cancer Therapy by Extracellular Matrix Remodeling

Zheng, M., Zhang, H., Dai, M., Yu, H., Hu, Y., Cheng, L., Wang, H., Chen, Q., Tan, M., Guo, Y., et al. (2025) · Nano Letters · doi:10.1021/acs.nanolett.4c05625 · Cited by 26

Targeting collagen to optimize cancer immunotherapy

Wang, Y., Zhang, F., Qian, Z., Ying, J., Wu, D., Liu, L., Ning, X., Mei, J., Chen, D., & Zhang, Y. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00691-y · Cited by 28

Expression Profiling of Extracellular Matrix Genes Reveals Global and Entity-Specific Characteristics in Adenoid Cystic, Mucoepidermoid and Salivary Duct Carcinomas

Arolt, C., Meyer, M. F., Hoffmann, F. S., Wagener‐Ryczek, S., Schwarz, D., Nachtsheim, L., Beutner, D., Odenthal, M., Guntinas‐Lichius, O., Buettner, R., et al. (2020) · Cancers · doi:10.3390/cancers12092466 · Cited by 25

Theragnostic nanomotors: Successes and upcoming challenges

Ramachandran, R. V., Bhat, R., Saini, D. K., & Ghosh, A. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1736 · Cited by 25

Impact of a Desmoplastic Tumor Microenvironment for Colon Cancer Drug Sensitivity: A Study with 3D Chimeric Tumor Spheroids

Goudar, V. S., Koduri, M. P., Ta, Y. N., Chen, Y., Chu, L., Lu, L., & Tseng, F. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c18249 · Cited by 25

Improving drug penetration to curb tumor drug resistance

Marcucci, F., & Corti, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.06.004 · Cited by 26

Anticancer lipid-based drug delivery systems: Basic knowledge and recent applications

Shehata, M. M. (2024) · Nano TransMed · doi:10.1016/j.ntm.2024.100054 · Cited by 25

Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation

Wadsworth, B. J., Cederberg, R. A., Lee, C.-M., Firmino, N. S., Franks, S. E., Pan, J., Colpo, N., Lin, K., Bénard, F., & Bennewith, K. L. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.015 · Cited by 26

The role of viral infectivity in oncolytic virotherapy outcomes: A mathematical study

Pooladvand, P., Yun, C., Yoon, A. R., Kim, P., & Frascoli, F. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108520 · Cited by 24

The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer

Khoshghamat, N., Jafari, N., Tolou, V., Azami, S., Mirnourbakhsh, S. H., Khazaei, M., Ferns, G. A., Rajabian, M., & Avan, A. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119118 · Cited by 24

Overcoming Therapy Resistance and Relapse in TNBC: Emerging Technologies to Target Breast Cancer-Associated Fibroblasts

Mollah, F., & Varamini, P. (2021) · Biomedicines · doi:10.3390/biomedicines9121921 · Cited by 24

Pancreatic ductal adenocarcinoma: tumor microenvironment and problems in the development of novel therapeutic strategies

Kuznetsova, A. V., Попова, О. П., Panchenkov, D. N., Dyuzheva, Т. G., & Aa, I. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00886-1 · Cited by 24

Enhanced photothermal and chemotherapy of pancreatic tumors by degrading the extracellular matrix

Cheng, Y., Zheng, X., Zhang, L., Zhao, J., Hu, L., & Wang, S. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.113010 · Cited by 24

Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits

Datta, M., Via, L. E., Dartois, V. A., Weiner, D. M., Zimmerman, M., Kaya, F., Walker, A. M., Fleegle, J. D., Raplee, I., McNinch, C., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321336121 · Cited by 23

The Use of Second Harmonic Generation to Image the Extracellular Matrix During Tumor Progression

Burke, K. A., & Brown, E. B. (2014) · IntraVital · doi:10.4161/21659087.2014.984509 · Cited by 24

Multiphoton fluorescence lifetime imaging of chemotherapy distribution in solid tumors

Carlson, M., Watson, A. L., Anderson, L. K., Largaespada, D. A., & Provenzano, P. P. (2017) · Journal of Biomedical Optics · doi:10.1117/1.jbo.22.11.116010 · Cited by 24

The plasticity of cancer-associated fibroblasts

Xia, Z., & Wever, O. D. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.012 · Cited by 27

Therapeutic application of the CRISPR system: current issues and new prospects

Lee, M., & Kim, S. (2019) · Human Genetics · doi:10.1007/s00439-019-02028-2 · Cited by 23

Gene and cell therapy for pancreatic cancer

Singh, H. M., Ungerechts, G., & Tsimberidou, A. M. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1001734 · Cited by 23

Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer

Cerullo, M., Gani, F., Chen, S. Y., Canner, J. K., & Pawlik, T. M. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-4021-8 · Cited by 23

Potential drug delivery nanosystems for improving tumor penetration

Peng, F., Li, R., Zhang, F., Qin, L., Ling, G., & Zhang, P. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.04.009 · Cited by 23

CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance

Coursier, D., & Calvo, F. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00931-z · Cited by 23

Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment

Vitorakis, N., Gargalionis, A. N., Papavassiliou, K. A., Adamopoulos, C., & Papavassiliou, A. G. (2024) · Cancers · doi:10.3390/cancers16162876 · Cited by 25

Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer

Sun, Y., Yin, Z., Li, S., Wu, L., Zhang, Y., Zhao, Y., SANTOS, I. L. G. D., Subudhi, S., Lei, P., Muzikansky, A., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02863-9 · Cited by 23

The extracellular matrix in inflammation and cancer

Zhang, W., Xiang, Y., Lu, C., Wang, F., Ren, H., Wu, H., & Yan, M. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00415-6 · Cited by 34

Measurement of Tumor Pressure and Strategies of Imaging Tumor Pressure for Radioimmunotherapy

Kim, H., Yu, A., Lee, J., Lee, Y., Lim, S. M., & Kim, J. S. (2019) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-019-00598-7 · Cited by 22

The role of the renin-angiotensin system inhibitors in malignancy: a review.

Yang, J., Yang, X., Gao, L., Zhang, J., Cheng, Y., & Huang, Y. (2021) · PubMed Central · Cited by 22

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer

Singh, H. M., Leber, M. F., Bossow, S., Engeland, C. E., Dessila, J., Grossardt, C., Zaoui, K., Bell, J. C., Jäger, D., Kalle, C. V., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.04.015 · Cited by 23

Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy

Yu, N., Zhang, X., Zhong, H., Mu, J., Li, X., Liu, T., Shi, X., Liang, X., & Guo, S. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c03663 · Cited by 22

Antifibrotic effects of pentoxifylline improve the efficacy of gemcitabine in human pancreatic tumor xenografts

Kim, J. H., Shin, B. C., Park, W. S., Lee, J., & Kuh, H. (2017) · Cancer Science · doi:10.1111/cas.13405 · Cited by 22

In Situ Drug Delivery to Breast Cancer-Associated Extracellular Matrix

Fleming, J. M., Yeyeodu, S. T., McLaughlin, A., Schuman, D., & Taylor, D. K. (2018) · ACS Chemical Biology · doi:10.1021/acschembio.8b00396 · Cited by 24

Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity

Vallejo-Ardila, D. L., Fifis, T., Burrell, L. M., Walsh, K. A., & Christophi, C. (2018) · Oncotarget · doi:10.18632/oncotarget.26174 · Cited by 22

Melanin-like nanoparticles loaded with an angiotensin antagonist for an improved photothermal cancer therapy

Zhou, Z., Yang, Y., Zhang, Q., & Cheng, Y. (2020) · Biomaterials Science · doi:10.1039/c9bm01843c · Cited by 22

Fibrotic Fortresses and Therapeutic Frontiers: Pancreatic Stellate Cells and the Extracellular Matrix in Pancreatic Cancer

Sığırlı, S., & Karakaş, D. (2025) · Cancer Medicine · doi:10.1002/cam4.70788 · Cited by 24

Nanoparticles for tumor targeting

Jiang, T., Jin, K., Liu, X., & Pang, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-101914-6.00008-9 · Cited by 22

Clinical Failure of Nanoparticles in Cancer: Mimicking Nature'S Solutions

Hernández-Camarero, P., Amezcua, V., Jiménez, G., García, M. Á., Marchal, J. A., & Perán, M. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0234 · Cited by 21

The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer

Raskov, H., Gaggar, S., Tajik, A., Orhan, A., & Gögenür, I. (2023) · Cancers · doi:10.3390/cancers15072057 · Cited by 23

Stress alleviation strategy in cancer treatment: Insights from a mathematical model

Mpekris, F., Voutouri, C., Papageorgis, P., & Stylianopoulos, T. (2018) · ZAMM ‐ Journal of Applied Mathematics and Mechanics / Zeitschrift für Angewandte Mathematik und Mechanik · doi:10.1002/zamm.201700270 · Cited by 21

Phenotypic heterogeneity and tumor immune microenvironment directed therapeutic strategies in pancreatic ductal adenocarcinoma

Ramesh, R. P. G., Yasmin, H., Ponnachan, P., al-Ramadi, B. K., Kishore, U., & Joseph, A. M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1573522 · Cited by 22

Spatial transcriptomics reveals a key role of fibroblast-like vascular smooth muscle cells in human atherosclerotic cell crosstalk and stability

Gonçalves, I., Pan, M., Singh, P., Wang, W., Zhao, J., Dib, L. H., Sundius, L., Persson, A. F., Gialeli, C., Fountas, P., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf1091 · Cited by 22

Theranostic mesoporous platinum nanoplatform delivers halofuginone to remodel extracellular matrix of breast cancer without systematic toxicity

Zhang, J., Xu, Z., Li, Y., Hu, Y., Tang, J., Xu, J., Luo, Y., Wu, F., Sun, X., Tang, Y., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10427 · Cited by 20

Targeted delivery of nanomedicines to glioblastoma: Overcoming the clinical barrier

Nayak, A., Warrier, N. M., Raman, R., Prabhu, V., & Kumar, P. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105980 · Cited by 21

Oncolytic virus and tumor-associated macrophage interactions in cancer immunotherapy

Lecoultre, M., Walker, P. R., & Helali, A. E. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01443-8 · Cited by 23

Complex adaptive therapeutic strategy (CATS) for cancer

Cho, Y. W., Kim, S. Y., Kwon, I. C., & Kim, I.-S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.017 · Cited by 20

Trisulfide linked cholesteryl PEG conjugate attenuates intracellular ROS and collagen-1 production in a breast cancer co-culture model

Dao, N. V., Ercole, F., Urquhart, M. C., Kaminskas, L. M., Nowell, C. J., Davis, T. P., Sloan, E. K., Whittaker, M. R., & Quinn, J. F. (2020) · Biomaterials Science · doi:10.1039/d0bm01544j · Cited by 21

Modelling and breaking down the biophysical barriers to drug delivery in pancreatic cancer

Kpeglo, D., Haddrick, M., Knowles, M. A., Evans, S. D., & Peyman, S. A. (2024) · Lab on a Chip · doi:10.1039/d3lc00660c · Cited by 21

Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment

Hou, X., Shen, Y., Huang, B., Li, Q., Li, S., Jiang, T., Shan, X., Xu, W., Liu, S., Wu, S., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02871-0 · Cited by 19

Multidrug micelles and sonopermeation for chemotherapy co-delivery to brain tumors

Dasgupta, A., May, J., Klinkenberg, G., Besse, H. C., Buhl, E. M., Moeckel, D., Mihyar, R., Peña, Q., Shalmani, A. A., Hark, C., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.018 · Cited by 19

The synergistic potential of mechanotherapy and sonopermeation to enhance cancer treatment effectiveness

Neophytou, C., Stylianopoulos, T., & Mpekris, F. (2025) · npj Biological Physics and Mechanics. · doi:10.1038/s44341-025-00017-3 · Cited by 20

A New Imaging Platform for Visualizing Biological Effects of Non-Invasive Radiofrequency Electric-Field Cancer Hyperthermia

Corr, S. J., Shamsudeen, S., Vergara, L. A., Ho, J. C.-S., Ware, M. J., Keshishian, V., Yokoi, K., Savage, D. J., Meraz, I. M., Kaluarachchi, W. D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136382 · Cited by 19

Targeting tumor microenvironment and metastasis in children with solid tumors

Wessel, K. M., & Kaplan, R. N. (2021) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000001082 · Cited by 20

Stromal Characteristics and Impact on New Therapies for Metastatic Triple-Negative Breast Cancer

Fertal, S. A., Poterala, J. E., Ponik, S. M., & Wisinski, K. B. (2022) · Cancers · doi:10.3390/cancers14051238 · Cited by 20

Exploration of Site-Specific Drug Targeting—A Review on EPR-, Stimuli-, Chemical-, and Receptor-Based Approaches as Potential Drug Targeting Methods in Cancer Treatment

Rasel, M. S. I., Mohona, F. A., Akter, W., Kabir, S., Chowdhury, A. A., Chowdhury, J. A., Hassan, M. A., Mamun, A. A., Ghose, D. K., Ahmad, Z., et al. (2022) · Journal of Oncology · doi:10.1155/2022/9396760 · Cited by 21

Multifunctional ROS-Responsive and TME-Modulated Lipid-Polymer Hybrid Nanoparticles for Enhanced Tumor Penetration

Ni, R., Huang, L., Li, Z., Zhang, W., Wang, Y., Shen, Y., Wang, J., & Lu, W. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s383517 · Cited by 19

siRNA-Encapsulated Biomimetic Liposomes Effectively Inhibit Tumor Cells’ Hexosamine Biosynthesis Pathway for Attenuating Hyaluronan Barriers to Pancreatic Cancer Chemotherapy

Wu, J., Cheng, Y., Qian, K., Yang, P., Zhou, L., Xu, M., Sheng, D., Wang, T., Li, Y., Yang, X., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c14969 · Cited by 19

Promising oncolytic agents for metastatic breast cancer treatment

Hurst, D. R., & Cody, J. J. (2015) · Oncolytic Virotherapy · doi:10.2147/ov.s63045 · Cited by 19

Breast cancer and the renin-angiotensin system (RAS): Therapeutic approaches and related metabolic diseases

de Miranda, F. S., Guimarães, J. P. T., Menikdiwela, K. R., Mabry, B., Dhakal, R., Rahman, R. L., Moussa, H. M., & Moustaïd‐Moussa, N. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111245 · Cited by 19

The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer

Sequeira, G. R., Vanzulli, S. I., Rojas, P. A., Lamb, C. A., Colombo, L. L., May, M., Molinolo, A., & Lanari, C. (2014) · Oncotarget · doi:10.18632/oncotarget.1922 · Cited by 19

A functional nanocarrier that copenetrates extracellular matrix and multiple layers of tumor cells for sequential and deep tumor autophagy inhibitor and chemotherapeutic delivery

Wang, Y., Qiu, Y., Yin, S., Zhang, L., Shi, K., Gao, H., Zhang, Z., & He, Q. (2016) · Autophagy · doi:10.1080/15548627.2016.1256523 · Cited by 19

Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies

du Toit‐Thompson, T., Leck, L. Y. W., Gillson, J., Pavlakis, N., Gill, A. J., Samra, J. S., Mittal, A., & Sahni, S. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115647 · Cited by 20

Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer

Bryce, A. S., Dreyer, S. B., Froeling, F. E. M., & Chang, D. K.-F. (2022) · Cancers · doi:10.3390/cancers14215302 · Cited by 19

Antitumor Therapy Targeting the Tumor Microenvironment

Gao, Y., Pan, Z., Li, H., & Wang, F. (2023) · Journal of Oncology · doi:10.1155/2023/6886135 · Cited by 19

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype

Wolf, B., Weydandt, L., Dornhöfer, N., Hiller, G. G. R., Höhn, A. K., Nel, I., Jain, R. K., Horn, L., & Aktas, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-46340-4 · Cited by 21

Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots

Wang, J., Xu, J., Li, J., Zhao, M., Zhang, H.-F., Liu, D., Zhou, X. M., & Xu, H. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24695 · Cited by 18

Recent Advances in Strategies for Extracellular Matrix Degradation and Synthesis Inhibition for Improved Therapy of Solid Tumors

Sandha, K. K., Shukla, M. K., & Gupta, P. N. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200728141601 · Cited by 18

Visualization of the distribution of nanoparticle-formulated AZD2811 in mouse tumor model using matrix-assisted laser desorption ionization mass spectrometry imaging

Ryu, S., Ohuchi, M., Yagishita, S., Shimoi, T., Yonemori, K., Tamura, K., Fujiwara, Y., & Hamada, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-72665-5 · Cited by 18

Vascular and Interstitial Biology of Tumors

Jain, R. K., Chauhan, V. P., & Duda, D. G. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00008-4 · Cited by 18

The Role of Mitochondrial Dynamin in Stroke

Li, C., Chen, C., Qin, H., Ao, C., Chen, J., Tan, J., & Zeng, L. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2504798 · Cited by 19

Renin‐angiotensin system blockade modulates both the peripheral and central components of neuropathic pain in rats: Role of calcitonin gene–related peptide, substance P and nitric oxide

Hegazy, N., Rezq, S., & Fahmy, A. (2020) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13453 · Cited by 17

Therapeutic agents for targeting desmoplasia: current status and emerging trends

Nandi, T., Pradyuth, S. K., Singh, A. K., Chitkara, D., & Mittal, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.008 · Cited by 19

CCL5 production by fibroblasts through a local renin–angiotensin system in malignant melanoma affects tumor immune responses

Nakamura, K., Kiniwa, Y., & Okuyama, R. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03612-8 · Cited by 18

Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer

Shah, V. M., Dorrell, C., Fatease, A. M. A., Allen-Petersen, B. L., Woo, Y., Bortnyak, Y., Gheewala, R., Sheppard, B. C., Sears, R. C., & Alani, A. W. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040713 · Cited by 18

Small molecules convey big messages: Boosting non-viral nucleic acid delivery with low molecular weight drugs

Joris, F., Smedt, S. C. D., & Raemdonck, K. (2017) · Nano Today · doi:10.1016/j.nantod.2017.06.012 · Cited by 17

Clinical applicability of renin-angiotensin system inhibitors in cancer treatment.

Jiang, H., Tai, Z., Chen, Z., Zhu, Q., & Bao, L. (2021) · PubMed Central · Cited by 15

Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells

Panza, S., Malivindi, R., Caruso, A., Russo, U., Giordano, F., Győrffy, B., Gelsomino, L., Amicis, F. D., Barone, I., Conforti, F. L., et al. (2021) · Cancers · doi:10.3390/cancers13184555 · Cited by 17

Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition

Martin, J. D., Lanning, R. M., Chauhan, V. P., Martin, M. R., Mousa, A. S., Kamoun, W. S., Han, H., Lee, H., Stylianopoulos, T., Bawendi, M. G., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0486 · Cited by 16

Engineered probiotic-mediated intratumoral delivery and controlled release of bacterial collagenase for cancer therapy

Li, H., & Ye, B. (2024) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2024.09.001 · Cited by 16

Understanding the In Vivo Fate of Advanced Materials by Imaging

Li, R., Ng, T. S. C., Garlin, M. A., Weissleder, R., & Miller, M. A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910369 · Cited by 18

Imaging methods to evaluate tumor microenvironment factors affecting nanoparticle drug delivery and antitumor response

Moody, A. S., Dayton, P. A., & Zamboni, W. C. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2020.94 · Cited by 18

Liposome-Encapsulated Tiancimycin A Is Active against Melanoma and Metastatic Breast Tumors: The Effect of cRGD Modification of the Liposomal Carrier and Tiancimycin A Dose on Drug Activity and Toxicity

Feng, X., Liu, H., Pan, J. M., Xiong, Y., Zhu, X., Yan, X., Duan, Y., & Huang, Y. P. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00753 · Cited by 17

Nanotechnology as a Delivery Tool for Precision Cancer Therapies

Sharma, B., Crist, R. M., & Adiseshaiah, P. P. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0152-y · Cited by 16

Arachidonic acid triggers spermidine synthase secretion from primary tumor to induce skeletal muscle weakness upon irradiation

Zhang, X. H., Nie, Z., Wang, S., Ma, Y., Han, D., Hu, T., Liu, L., Men, L., Zhang, T., Wu, X., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.05.013 · Cited by 16

A single photodynamic priming protocol augments delivery of ⍺‐ PD ‐ L 1 m A bs and induces immunogenic cell death in head and neck tumors

Bhandari, C., Moffat, A., Fakhry, J., Malkoochi, A., Nguyen, A., Trinh, B., Hoyt, K., Story, M. D., Hasan, T. G., & Obaid, G. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13865 · Cited by 15

The tumor immune microenvironment in pancreatic cancer and its potential in the identification of immunotherapy biomarkers

Tsunedomi, R., Shindo, Y., Nakajima, M., Yoshimura, K., & Nagano, H. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2281482 · Cited by 15

Tumor Microenvironment Reprogramming Improves Nanomedicine-Based Chemo-Immunotherapy in Sarcomas

Charalambous, A., Mpekris, F., Panagi, M., Voutouri, C., Michael, C., Gabizón, A., & Stylianopoulos, T. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0772 · Cited by 16

A biomimetic dual-targeting nanomedicine for pancreatic cancer therapy

Zhou, G., Zhang, Y., Cai, Z., Yao, H., Liu, M., Jiang, C., & Cheng, Z. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02206h · Cited by 16

Asiatic acid enhances intratumor delivery and the antitumor effect of pegylated liposomal doxorubicin by reducing tumor-stroma collagen

Fang, L., Kong, S., Zhong, L., Wang, C.-M., Liu, Y., Ding, H., Sun, J., Zhang, Y., Li, F., & Huang, P. C. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0038-2 · Cited by 15

PAX8 modulates the tumor microenvironment of high grade serous ovarian cancer through changes in the secretome

Salvi, A., Hardy, L. R., Heath, K. N., Watry, S., Pergande, M. R., Cologna, S. M., & Burdette, J. E. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100866 · Cited by 15

Activated fibroblasts in cardiac and cancer fibrosis: An overview of analogies and new potential therapeutic options

Nicolini, G., Balzan, S., & Forini, F. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121575 · Cited by 18

Application of vasoactive and matrix-modifying drugs can improve polyplex delivery to tumors upon intravenous administration

Durymanov, M. O., Yarutkin, A. V., Bagrov, D. V., Klinov, D. V., Kedrov, A. V., Chemeris, N. K., Rosenkranz, A. A., & Sobolev, A. S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.011 · Cited by 15

Spatial proteomics of skeletal muscle using thin cryosections reveals metabolic adaptation at the muscle-tendon transition zone

Schmidt, L., Saynisch, M., Hoegsbjerg, C., Schmidt, A., Mackey, A. L., Lackmann, J., Müller, S., Koch, M., Brachvogel, B., Kjaer, M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114374 · Cited by 15

An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas

Stergiopoulos, G. M., Concilio, S. C., & Galanis, E. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01211-6 · Cited by 16

Interpretable Radiomics Model Predicts Nanomedicine Tumor Accumulation Using Routine Medical Imaging

Tang, J., Zhang, J., Li, Y., Hu, Y., He, D., Ni, H., Zhang, J., Wu, F., Tang, Y., & Wang, S. (2025) · Advanced Materials · doi:10.1002/adma.202416696 · Cited by 14

Increased Fibrosis and Interstitial Fluid Pressure in Two Different Types of Syngeneic Murine Carcinoma Grown in Integrin β3-Subunit Deficient Mice

Friman, T., Gustafsson, R., Stuhr, L. E. B., Chidiac, J., Heldin, N., Reed, R. K., Oldberg, Å., & Rubin, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034082 · Cited by 14

Oncolytic virotherapy – A novel strategy for cancer therapy

Gopisankar, M. G., & Surendiran, A. (2017) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2017.10.006 · Cited by 14

Development of an in vitro model to test antifibrotic drugs on primary human liver myofibroblasts

Aoudjehane, L., Boëlle, P., Bisch, G., Delelo, R., Paye, F., Scatton, O., Housset, C., Becquart, J., Calmus, Y., & Conti, F. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.36 · Cited by 14

Mathematical modeling of the heterogeneous distributions of nanomedicines in solid tumors

He, H., Liu, C., Liu, Y., Liu, X., Wu, Y., Fan, J., Zhao, L. Y., & Cao, Y. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.06.005 · Cited by 14

Losartan loaded liposomes improve the antitumor efficacy of liposomal paclitaxel modified with pH sensitive peptides by inhibition of collagen in breast cancer

Xia, T., He, Q., Shi, K., Wang, Y., Yu, Q., Zhang, L., Zhang, Q., Gao, H., Ma, L., & Liu, J. (2016) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2016.1265553 · Cited by 51

A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan

Cun, X., Ruan, S., Chen, J., Zhang, L., Li, J., He, Q., & Gao, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.12.002 · Cited by 115

Depletion of collagen by losartan to improve tumor accumulation and therapeutic efficacy of photodynamic nanoplatforms

Tang, Y., Liu, Y., Wang, S., Tian, Y., Li, Y., Teng, Z., & Lu, G. (2019) · Drug Delivery and Translational Research · doi:10.1007/s13346-018-00610-1 · Cited by 31

Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity

Yu, M., Zhang, C., Tang, Z., Tang, X., & Xu, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.011 · Cited by 51

High Tumor Penetration of Paclitaxel Loaded pH Sensitive Cleavable Liposomes by Depletion of Tumor Collagen I in Breast Cancer

Zhang, L., Wang, Y., Yang, Y., Liu, Y., Ruan, S., Zhang, Q., Tai, X., Chen, J., Xia, T., Qiu, Y., et al. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b01473 · Cited by 108